Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
90.0%
-
Total 13F principal
-
$514,547,508
-
Principal change
-
+$11,123,804
-
Total reported market value
-
$466,687,900
-
Number of holders
-
40
-
Value change
-
+$10,040,765
-
Number of buys
-
15
-
Number of sells
-
12
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q1 2022
As of 31 Mar 2022,
IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$514,547,508
in principal (par value) of the bond.
The largest 10 bondholders included
DeepCurrents Investment Group LLC, TENOR CAPITAL MANAGEMENT Co., L.P., AVIVA PLC, STEELHEAD PARTNERS LLC, D. E. Shaw & Co., Inc., Opti Capital Management, LP, CAMDEN ASSET MANAGEMENT L P /CA, Verition Fund Management LLC, OAKTREE CAPITAL MANAGEMENT LP, and Thrivent Financial for Lutherans.
This page lists
40
institutional bondholders reporting positions
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.